A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms

Current Medical Research and Opinion

Volumn 27, Issue 10, 2011, Pages 1849-1858

  Gaynor, Paula J ^a   Gopal, Murali ^b   Zheng, Wei ^a   Martinez, James M ^a   Robinson, Michael J ^a   Marangell, Lauren B ^a,c  

^a ELI LILLY AND COMPANY   (United States)

^b DWA Healthcare Communications Group   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Duloxetine; Major depressive disorder; Pain; Randomized clinical trial

Indexed keywords

DULOXETINE; PLACEBO;

ADULT; ARTICLE; BRIEF PAIN INVENTORY; CLINICAL ASSESSMENT; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERHIDROSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; OUTPATIENT; PAIN; PAIN ASSESSMENT; PHASE 4 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SOMNOLENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; REMISSION INDUCTION; THIOPHENES; TIME FACTORS;

EID: 80053018145     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.609539     Document Type: Article

References (21)

1. Vaccarino AL, Sills TL, Evans KR, et al. Multiple pain complaints in patients with major depressive disorder. Psychosom Med 2009;71:159-62
2. Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433-45 (Pubitemid 37385786)
3. Bair MJ, Robinson RL, Eckert GJ, et al. Impact of pain on depression treatment response in primary care. Psychosom Med 2004;66:17-22 (Pubitemid 38146528)
4. Fava M, Mallinckrodt CH, Detke MJ, et al. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004;65:521-30
5. Gameroff MJ, Olfson M. Major depressive disorder, somatic pain, and health care costs in an urban primary care practice. J Clin Psychiatry 2006; 67:1232-9 (Pubitemid 44439695)
6. Munoz RA, McBride ME, Brnabic AJ, et al. Major depressive disorder in Latin America: the relationship between depression severity, painful somatic symptoms, and quality of life. J Affect Disord 2005;86:93-8 (Pubitemid 40487965)
7. Bahk WM, Park S, Jon DI, et al. Relationship between painful physical symptoms and severity of depressive symptomatology and suicidality. Psychiatry Res 2011: published online, doi:S0165-1781(11)00043-6 [pii];10.1016/j. psychres.2011.01.009
8. Husain MM, Rush AJ, Trivedi MH, et al. Pain in depression: STAR*D study findings. J Psychosom Res 2007;63:113-22 (Pubitemid 47088549)
9. Li HC, Zhang MY, Wang G, et al. Association between painful physical symptoms and clinical outcomes in Chinese patients with major depressive disorder: a three-month observational study. Chin Med J (Engl) 2010; 123:2063-9
10. Cymbalta prescribing information. Available at: http://www.cymbalta.com/ index.jsp [Last accessed 5 May 2011]
11. Brannan SK, Mallinckrodt CH, Brown EB, et al. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res 2005;39:43-53 (Pubitemid 39422285)
12. Brecht S, Courtecuisse C, Debieuvre C, et al. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. J Clin Psychiatry 2007;68:1707-16 (Pubitemid 350247500)
13. WHO's pain ladder. Available at: http://www.who.int/cancer/palliative/ painladder/en/[Last accessed 15 July 2011]
14. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-38
15. Montgomery SA,A°sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9 (Pubitemid 9136500)
16. Dmitrienko A, Offen WW, Westfall PH. Gatekeeping strategies for clinical trials that do not require all primary effects to be significant. Stat Med 2003;22: 2387-400 (Pubitemid 36949661)
17. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11(Suppl 3):89-95 (Pubitemid 26373761)
18. Leon AC, Olfson M, Portera L, et al. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997; 27:93-105 (Pubitemid 27407503)
19. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville (MD): National Institute of Mental Health, Early Clinical Drug Evaluation, Psychopharmacology Research Branch, 1976
20. Farrar JT, Young Jr JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58 (Pubitemid 33016608)
21. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007; 164:1035-43 (Pubitemid 47121392)